Compare Nuvalent Inc (NUVL) vs RLX Technology Inc (RLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs RLX Technology Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while RLX Technology Inc trades at $2.03 (market cap $2.52B). The key difference: Nuvalent Inc is far larger — about 3.9× RLX Technology Inc's market cap, and RLX Technology Inc pays a 4.85% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | RLX | |
|---|---|---|
Market Cap | $9.81B | $2.52B |
Sector | Technology | Technology |
52-Week High | $123.96 | $2.73 |
52-Week Low | $72.16 | $1.79 |
Enterprise Value | $8.52B | $1.15B |
Dividend Yield | — | 4.85% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →
